Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

This study has been completed.
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: February 19, 2008
Last updated: March 25, 2013
Last verified: January 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2009
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)